Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Year-over-year operating income growth rate
Latest
6.93%
↑ 155% vs avg
Percentile
P75
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-12.68%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 6.93% |
| Q3 2025 | 12.01% |
| Q2 2025 | -5.17% |
| Q1 2025 | 14.14% |
| Q4 2024 | 13.87% |
| Q3 2024 | -33.07% |
| Q2 2024 | -27.73% |
| Q1 2024 | -27.61% |
| Q4 2023 | -5.47% |
| Q3 2023 | -66.97% |
| Q2 2023 | -5.34% |
| Q1 2023 | -49.26% |
| Q4 2022 | -34.82% |
| Q3 2022 | -14.57% |
| Q2 2022 | 14.40% |
| Q1 2022 | -6.86% |
| Q4 2021 | 0.00% |